NDC11 51326017601
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 51326-0176-01 | 51326-0176 |
| 51326-0176-1 | 51326-0176 |
| 51326-176-01 | 51326-176 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RFA BPO Acne Treatment 2.5% | BENZOYL PEROXIDE | Topiderm, Inc. | c5053e9e-7608-45d9-9b9b-9b93210eb917 | 2026-07-27 | Warnings | 51326-176-01 51326-176 51326017601 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.